Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects

B López, A González, N Hermida… - American Journal …, 2010 - journals.physiology.org
Because of its dynamic nature, the composition and structure of the myocardial collagen
network can be reversibly modified to adapt to transient cardiac injuries. In response to …

Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches

B López, S Ravassa, MU Moreno, GS José… - Nature Reviews …, 2021 - nature.com
Diffuse myocardial fibrosis resulting from the excessive deposition of collagen fibres through
the entire myocardium is encountered in a number of chronic cardiac diseases. This lesion …

Circulating biomarkers of myocardial fibrosis: the need for a reappraisal

B López, A González, S Ravassa, J Beaumont… - Journal of the American …, 2015 - jacc.org
Myocardial fibrosis impairs cardiac function, in addition to facilitating arrhythmias and
ischemia, and thus influences the evolution and outcome of cardiac diseases. Its …

Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients

J Díez, R Querejeta, B López, A González, M Larman… - Circulation, 2002 - Am Heart Assoc
Background—This study was designed to investigate whether myocardial collagen content
is related to myocardial stiffness in patients with essential hypertension. Methods and …

[HTML][HTML] Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy

CY Ho, B López, OR Coelho-Filho… - … England Journal of …, 2010 - Mass Medical Soc
Background Myocardial fibrosis is a hallmark of hypertrophic cardiomyopathy and a
proposed substrate for arrhythmias and heart failure. In animal models, profibrotic genetic …

Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis

R Querejeta, B López, A González, E Sánchez… - Circulation, 2004 - Am Heart Assoc
Background—We investigated whether increased collagen type I synthesis and deposition
contribute to enhancement of myocardial fibrosis and deterioration of cardiac function in …

Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure

B López, R Querejeta, A González, E Sánchez… - Journal of the American …, 2004 - jacc.org
Objectives: This individually randomized, open-label, parallel-group pilot study was
designed to test the hypothesis that the ability of loop diuretics to interfere with cardiac …

Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction

M Kasner, D Westermann, B Lopez, R Gaub… - Journal of the American …, 2011 - jacc.org
Objectives: We attempted to correlate echocardiographic analysis of diastolic function with
changes of myocardial collagen in middle-aged patients with heart failure (HF) despite …

Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive …

B López, R Querejeta, N Varo, A González, M Larman… - Circulation, 2001 - Am Heart Assoc
Background We investigated whether serum concentration of carboxy-terminal propeptide of
procollagen type I (PIP), a marker of collagen type I synthesis, can be used to assess the …

Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model

N Hamdani, C Franssen, A Lourenço… - Circulation: Heart …, 2013 - Am Heart Assoc
Background—Obesity and diabetes mellitus are important metabolic risk factors and
frequent comorbidities in heart failure with preserved ejection fraction. They contribute to …